These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12227158)

  • 1. [Topics on herpes simplex virus pathogenesis--roles of viral 'non-essential' genes and host immune status].
    Minagawa H
    Uirusu; 2002 Jun; 52(1):109-15. PubMed ID: 12227158
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunity to latent viral infection: many skirmishes but few fatalities.
    Khanna KM; Lepisto AJ; Hendricks RL
    Trends Immunol; 2004 May; 25(5):230-4. PubMed ID: 15099562
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
    Fraser NW; Valyi-Nagy T
    Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molecular biology of pathogenesis by herpesvirus].
    Barrón BL; Vales N
    Rev Latinoam Microbiol; 1991; 33(1):77-85. PubMed ID: 1670258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present status and task the in study of pathophysiologic mechanism of latent herpes simplex virus infection and the viral re-activation].
    Minagawa H
    Fukuoka Igaku Zasshi; 1995 Jul; 86(7):299-303. PubMed ID: 7665138
    [No Abstract]   [Full Text] [Related]  

  • 6. Repression of viral transcription during herpes simplex virus latency.
    Preston CM
    J Gen Virol; 2000 Jan; 81(Pt 1):1-19. PubMed ID: 10640537
    [No Abstract]   [Full Text] [Related]  

  • 7. The cycle of human herpes simplex virus infection: virus transport and immune control.
    Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW
    J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity in latent Herpes simplex virus infection.
    Bystrická M; Russ G
    Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes Simplex Virus Latency Is Noisier the Closer We Look.
    Singh N; Tscharke DC
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis.
    Branco FJ; Fraser NW
    J Virol; 2005 Jul; 79(14):9019-25. PubMed ID: 15994795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Herpes simplex virus: mechanism of latency and reactivation phases].
    Boulinguez S; Rogez S
    Ann Dermatol Venereol; 1997; 124(5):409-15. PubMed ID: 9739902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Latency of herpes simplex virus. Current knowledge].
    Catalán V; Gimeno C; García-de-Lomas J
    Enferm Infecc Microbiol Clin; 1991 Mar; 9(3):172-6. PubMed ID: 1650583
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
    Carter CJ
    Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards an understanding of the molecular basis of herpes simplex virus latency.
    Efstathiou S; Preston CM
    Virus Res; 2005 Aug; 111(2):108-19. PubMed ID: 15951043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?
    Mori I; Nishiyama Y
    Rev Med Virol; 2005; 15(6):393-406. PubMed ID: 16173110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Replication mechanisms and molecular pathogenesis of herpes simplex viruses].
    Ushijima Y; Nishiyama Y
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):953-60. PubMed ID: 21089523
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromatin control of herpes simplex virus lytic and latent infection.
    Knipe DM; Cliffe A
    Nat Rev Microbiol; 2008 Mar; 6(3):211-21. PubMed ID: 18264117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of herpes simplex virus infection].
    Kawaguchi Y
    Seikagaku; 2012 May; 84(5):343-51. PubMed ID: 22746056
    [No Abstract]   [Full Text] [Related]  

  • 19. Subversion of intracellular signal transduction by herpes simplex virus type 1.
    Halford WP; Carr DJ
    Adv Neuroimmunol; 1995; 5(3):327-34. PubMed ID: 8748076
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically engineered herpes simplex virus vaccines.
    Watson RJ; Enquist LW
    Prog Med Virol; 1985; 31():84-108. PubMed ID: 2982176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.